Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
Liliana Antunes, Clara Mazagatos, Iván Martínez‐Baz, et al.
Eurosurveillance (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 7
Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeting
Sara Boccalini, Angela Bechini, Marco Del Riccio, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort
Liam Townsend, Louise Marron, Katie M. O’Brien, et al.
QJM (2024) Vol. 117, Iss. 9, pp. 638-646
Closed Access | Times Cited: 4
Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024
Liliana Antunes, Clara Mazagatos, Iván Martínez‐Baz, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 8
Open Access | Times Cited: 2
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021–May 2023
Camelia Savulescu, Albert Prats‐Uribe, Kim Brolin, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1295-1295
Open Access | Times Cited: 2
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 58-58
Open Access | Times Cited: 1
Effectiveness of COVID-19 vaccines among children 6–11 years against hospitalization during Omicron predominance in Malaysia
Vivek Jason Jayaraj, Masliyana Husin, Jing Lian Suah, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis
Dritan Bejko, Corinna Ernst, Anne Vergison, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126011-126011
Open Access | Times Cited: 1
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 906-906
Open Access | Times Cited: 1
Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia
Danijela Đurić-Petković, Vesna Šuljagić, Vesna Begović-Kuprešanin, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 211-211
Open Access
COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022–2023): a test-negative case-control study from the EuroSAVE network
Mark A. Katz, Sandra Cohuet, Silvia Bino, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101095-101095
Open Access
Page 1

Scroll to top